Rhythm Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€42.40
Target price
19.12.24
€50.16
Performance (%)
30.90%
End price
20.12.24
€55.50
Summary
This prediction ended on 20.12.24 with a price of €55.50. With a performance of 30.90% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | 6.579% | 6.579% | 98.456% |
| iShares Core DAX® | 1.043% | -0.149% | 34.887% |
| iShares Nasdaq 100 | 1.920% | 4.604% | 18.366% |
| iShares Nikkei 225® | 4.840% | 8.328% | 10.637% |
| iShares S&P 500 | 1.567% | 3.310% | 13.043% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $55.00 price target on the stock, up previously from $29.00.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
79.49%
07:37
07:37
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
12.75%
07:37
07:37